Clinical Trial Update: Soylent in Reducing Gastrostomy Tube Rates in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at Jonsson Comprehensive Cancer Center is evaluating whether Soylent nutrition can reduce gastrostomy tube rates in patients with local…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Locally Advanced Head and Neck Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING